WuXi Biologics and GSK enter into licence agreement on multiple T Cell Engagers EP News Bureau Jan 6, 2023 WuXi Biologics will receive a $40 million upfront payment and up to $1.46 billion in additional payments for research,…
WuXi Biologics to acquire CMAB Biopharma Group EP News Bureau Mar 18, 2021 Form strategic partnership with CBC Group
